Free Trial
NASDAQ:LCAV

LCA-Vision (LCAV) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About LCA-Vision

LCA-Vision Inc. is a provider of fixed-site laser vision correction services at its LasikPlus vision centers. The Company's vision centers provide the staff, facilities, equipment and support services for performing laser vision correction that employ advanced laser technologies to help correct nearsightedness, farsightedness and astigmatism. The Company's vision centers are supported by independent, ophthalmologists and credentialed optometrists, as well as other healthcare professionals. The ophthalmologists perform the laser vision correction procedures in the Company's vision centers, and ophthalmologists or optometrists conduct pre-procedure evaluations and post-operative follow-up care in-center. Most of the Company's patients receive a procedure called laser-assisted in situ keratomileusis (LASIK). As of December 31, 2011, it had performed over 1.2 million laser vision correction procedures in its vision centers in the United States and Canada.

LCAV Stock News Headlines

See More Headlines
Receive LCAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LCA-Vision and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/30/2014
Today
6/17/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:LCAV
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

LCAV Stock Analysis - Frequently Asked Questions

How were LCA-Vision's earnings last quarter?

LCA-Vision Inc. (NASDAQ:LCAV) announced its quarterly earnings data on Wednesday, April, 30th. The healthcare company reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.23 by $0.24. The healthcare company earned $25.53 million during the quarter, compared to analysts' expectations of $32.04 million.

What other stocks do shareholders of LCA-Vision own?

Based on aggregate information from My MarketBeat watchlists, some companies that other LCA-Vision investors own include Amarin (AMRN), Dynatronics (DYNT), Genius Brands International (GNUS), iBio (IBIO), Inovio Pharmaceuticals (INO), Inseego (INSG), Nikola (NKLA), NortonLifeLock (NLOK), Novavax (NVAX) and BurgerFi International (OPES).

This page (NASDAQ:LCAV) was last updated on 6/17/2024 by MarketBeat.com Staff

From Our Partners